Search Results for "Baxter And Tianjin Pharma"
Original Source: Takeda Pharmaceutical Company Limited
1781 Founding Over two centuries ago in 1781, 32-year-old Chobei Takeda I started a business selling traditional Japanese and Chinese medicines in Doshomachi, Osaka, the center of the medicine trade in Japan. His small shop bought medicines from wholesalers, then divided them into smaller batches and sold them to local medicine merchants and doctors. This was the beginning of the present-day Takeda Chemical Industries, Ltd.
Matching Channels
Baxter is one of the 30 largest pharmaceutical companies in the world with annual sales of $7.8 billion. With a foot in both the pharmaceutical industry and medical devices, Baxter Healthcare has...
Matching News
Baxter is a global healthcare company with expertise in medical devices, pharmaceuticals and biotechnology. Return to top 50 pharma list Summary Website: Baxter Headquarters: Deerfield, Illinois, USA...
Baxter pharma deals on peritoneal dialysis development with CNIHA
Big pharma company Baxter pharma deals with Government to Increase Access to Renal Therapy and dialysis. The big pharma company has partnered with the Chinese National Institute of Hospital Administra...
Baxter is a top pharmaceutical company based in Deerfield, Illinois, USA. Baxter International was founded in 1931 by Donald Baxter, a medical doctor, as a manufacturer and distributor of intravenou...
Tianjin KingYork and Innovata HK to form a joint venture for asthma and COPD
Tianjin KingYork Group Innovata HK Limited have gotten together to form a JV, which will be located in Tianjin Economic-Technological Development Area. The new company, which will be known as Tianjin...
TEXT-Fitch rates Baxter Holding's IDRs 'A'/'F1'
Aug 3 - Fitch Ratings has assigned the following ratings to Baxter Holding B.V. (BHBV), a wholly owned subsidiary of Baxter International Inc. (Baxter; NYSE:BAX). --Issuer Default Rating (IDR) 'A';...
Tianjin KingYork and Innovata Announce $190 Million Asthma JV
Tianjin KingYork Group Co. and Innovata HK Limited have gotten together to form a JV, which will be located in Tianjin Economic-Technological Development Area (TEDA). The new company, which will be kn...
Tianjin City To Disqualify Hospitals From PCI Surgery For Overusing Stents
The Tianjin city health bureau will step up its oversight of coronary stent operations.
CurrentAgreements Deal Making Update : February 2013
This month we are providing you with an overview of deal making activity in the life sciences, covering partnering and M&A in January 2013. Deal of the month Joint venture agreement for Tianjin Ki...
Matching PubMed Articles
Is the cassie-baxter formula relevant?
The utility of the Cassie-Baxter formula to predict the apparent contact angle of a drop on rough hydrophobic surfaces has been questioned recently. To resolve this issue, experimental and numerical d...
Reply to "neutralizing activity of immunoglobulin preparations".
Polymorphisms in miRNA binding site: new insight into small cell lung cancer susceptibility.
Advances of nrf2 in chemoprevention of cancer.
Autoantibodies as the early diagnostic biomarkers for lung cancer
